Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma

Journal of Virological Methods

Volumn 91, Issue 1, 2001, Pages 67-74

  Anastassopoulou, Cleo G ^a   Touloumi, Giota ^a   Katsoulidou, Antigoni ^a   Hatzitheodorou, Helen ^a   Pappa, Maroudia ^a   Paraskevis, Dimitrios ^a   Lazanas, Marios ^b   Gargalianos, Panagiotis ^c   Hatzakis, Angelos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^c G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

Amplicor; Branched DNA; HIV 1 RNA; Viral load

Indexed keywords

VIRUS RNA;

ARTICLE; DNA DETERMINATION; EVALUATION; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; NONHUMAN; PLASMA; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS LOAD;

ADULT; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; DNA PROBES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 0035146997     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(00)00245-7     Document Type: Article

References (20)

1. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus Type-1 RNA levels
2. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
3. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml
4. Evaluation of the ultrasensitive roche amplicor HIV-1 monitor assay for quantitation of human immunodeficiency virus Type 1 RNA
5. Antiretroviral therapy in 1999 for antiretroviral-naïve individuals with HIV infection
6. Comparison of the quantiplex version 3.0 assay and a sensitized amplicor monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples
7. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200-500 CD4 cells per cubic millimeter
8. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
9. + lymphocytes as prognostic markers of HIV-1 infection
10. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: Enhanced sensitivity
11. Reproducibility and performance of the second-generation branched-DNA assay in routine quantification of human immunodeficiency virus Type 1 RNA in plasma
12. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus Type 1 RNA in plasma
13. + lymphocyte counts and the risk of progression to AIDS
14. Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA
15. Suppression of plasma viral load below 20 copies per ml is required to achieve a long-term response to therapy
16. Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy
17. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus Type 1 RNA in plasma
18. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus Type 1